Literature DB >> 36258121

A case of nephrogenic diabetes insipidus likely caused by anti-neutrophil cytoplastic antibody-associated vasculitis.

Kei Asakura1, Hiroaki Ogata1, Mutsuko Omatsu2, Masahiro Yamamoto1, Kiryu Yoshida3, Hidetoshi Ito1.   

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a relatively rare form of autoimmune disease. Diabetes insipidus (DI) is characterized by diluted polyuria and thirstiness, and is clinically categorized into central and nephrogenic DI depending on damaged organs. In most previously reported cases, ANCA-related disorders have been implicated in central DI, which is attributed to impaired secretion of arginine vasopressin (AVP) from the posterior pituitary. However, no previous case of AAV-related nephrogenic DI has been reported in the English literature. Herein, we report a case of nephrogenic DI likely caused by AAV. A 76-year-old man was admitted to our hospital for acute kidney injury. He showed dehydration, polyuria, and polydipsia. Laboratory tests demonstrated elevated levels of serum urea and creatinine and a high myeloperoxidase ANCA titer. In the present case, both plasma AVP concentration and response of AVP secretion to 5% saline load test were normal. In addition, 1-desmino-8-arginine vasopressin administration could not increase urinary osmolarity. Kidney biopsy specimen revealed tubulointerstitial nephritis with findings that appeared to indicate peritubular capillaritis. Therefore, the patient was diagnosed with nephrogenic DI likely owing to ANCA-associated tubulointerstitial nephritis. Immediately after prednisolone administration, urinary volume decreased, urinary osmolarity increased, and kidney function was improved. This case demonstrates that AAV that extensively affects the tubulointerstitial area can result in nephrogenic DI.
© 2022. The Author(s) under exclusive licence to The Japan Society of Nephrology.

Entities:  

Keywords:  Anti-neutrophil cytoplastic antibody-associated vasculitis; Nephrogenic diabetes insipidus; Tubulointerstitial nephritis

Year:  2022        PMID: 36258121     DOI: 10.1007/s13730-022-00741-y

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  9 in total

1.  Pituitary involvement in Wegener's granulomatosis: unusual biochemical findings and severe malnutrition.

Authors:  Carmen Tenorio Jimenez; Amparo Montalvo Valdivieso; Gema López Gallardo; Barbara Mcgowan
Journal:  BMJ Case Rep       Date:  2011-11-07

2.  Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener's granulomatosis.

Authors:  Nurşen Düzgün; Yonca Morris; Sevim Güllü; Alptekin Gürsoy; Arzu Ensari; Ozlem Ozdemir Kumbasar; Murat Duman
Journal:  Rheumatol Int       Date:  2005-04-28       Impact factor: 2.631

3.  Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis.

Authors:  Kimimasa Nakabayashi; Ayumi Sumiishi; Katuko Sano; Yasunori Fujioka; Akira Yamada; Miho Karube; Hitoshi Koji; Yoshihiro Arimura; Toshihiko Nagasawa
Journal:  Clin Exp Nephrol       Date:  2009-06-09       Impact factor: 2.801

4.  Wegener's granulomatosis complicated by central diabetes insipidus and peripheral neutrophy with normal pituitary in a patient.

Authors:  Jing Xue; Huiying Wang; Huaxiang Wu; Qiaofei Jin
Journal:  Rheumatol Int       Date:  2009-01-27       Impact factor: 2.631

Review 5.  Drug-associated renal dysfunction and injury.

Authors:  Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Clin Pract Nephrol       Date:  2006-02

6.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Authors:  Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

Review 7.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

8.  Renal involvement and followup of 130 patients with primary Sjögren's syndrome.

Authors:  Hon Ren; Wei-Ming Wang; Xiao-Nong Chen; Wen Zhang; Xiao-Xia Pan; Xiang-Ling Wang; Ying Lin; Su Zhang; Nan Chen
Journal:  J Rheumatol       Date:  2007-12-15       Impact factor: 4.666

9.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.